David Schlett joins Prime Therapeutics as Chief Financial Officer
Schlett is an experienced finance executive with more than 25 years of business, leadership experienceJanuary 9, 2020
Schlett has deep roots in health care and the pharmacy industry. He held finance leadership positions at Medco and served as Express Scripts’ senior vice president of finance. Most recently he worked for Cambridge Advisory Group, and operated his own independent consultancy, providing financial, pharmacy and health care advisory services.
“Dave is a perfect fit for Prime,” said Prime’s President and CEO Ken Paulus. “As we searched for a new CFO, we were fortunate to have this well-respected, highly sought-after finance professional serve as an advisor to us this past year. Dave exhibited the depth and breadth of experience that Prime needs in this crucial position. We are delighted to have him join our team during this transformative time in health care.”
“I’m delighted to join Prime at this point in the company’s evolution,” said David Schlett, Prime’s new CFO. “The industry continues to evolve and Prime is uniquely positioned to create the PBM of the future, providing total drug management leading to better patient outcomes and lower plan cost.”
Schlett earned both a Master of Business Administration in Finance and a Bachelor of Arts in Business Administration and Accounting from Rutgers University in New Brunswick, NJ. He also is a certified public accountant (CPA).
February 8, 2024
Designation demonstrates highest level of commitment to quality health care
December 5, 2023
EAGAN, Minn. – Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that…
November 29, 2023
EAGAN, Minn. – Nov. 29, 2023 – Prime Therapeutics LLC (Prime) and Magellan…